Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Acceptability of an Anti-Inflammatory Lifestyle Intervention for Emerging Adult Cancer Survivors

NCT06442397 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT06442397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06442397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Acceptability of an Anti-Inflammatory Lifestyle Intervention for Emerging Adult Cancer Survivors
Lead sponsor
Virginia Commonwealth University
Phase
Not applicable
Overall status
Withdrawn
Start date
October 30, 2024
Completion date
July 31, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

survivorship